Timely Addition of Insulin to Oral Therapy for Type 2 Diabetes
- 1 February 2002
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 25 (2), 395-396
- https://doi.org/10.2337/diacare.25.2.395
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Sulfonylurea InadequacyDiabetes Care, 2002
- Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes MellitusProgressive Requirement for Multiple Therapies (UKPDS 49)JAMA, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive DiseaseDiabetes, 1995
- U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study GroupDiabetes, 1995
- Bedtime insulin/daytime glipizide. Effective therapy for sulfonylurea failures in NIDDMDiabetes, 1995
- Bedtime Insulin/Daytime Glipizide: Effective Therapy for Sulfonylurea Failures in NIDDMDiabetes, 1995
- Combined Therapy for Obese Type 2 Diabetes: Suppertime Mixed Insulin with Daytime SulfonylureaThe American Journal of the Medical Sciences, 1992
- UK prospective diabetes study 7: Response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patientsMetabolism, 1990